Cite
MLA Citation
A. S. Sperling et al.. “P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM).” HemaSphere, vol. 6, n.d., pp. 1329–1330. http://access.bl.uk/ark:/81055/vdc_100159757189.0x000016